Look-alike sound-alike TJC changes

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to cmichalek@ismp.org. 

1 post / 0 new
Log in or register to post comments
Wed, 12/10/2025 - 13:08
#1
Erin Gavin
Erin Gavin's picture
Offline
Last seen: 23 hours 26 min ago
Joined: 08/02/2021 - 13:41
Look-alike sound-alike TJC changes

Hi all,
The new TJC standards do not include MM.01.02.01, which required a LASA list and annual review. MM.04.01.01 EP2 is moved to 14.01.01 EP3, so we still have the requirement for a policy that defines "precautions for ordering medications with look-alike or sound-alike names."
Reviewing LASA errors and maintaining the list is helpful for ensuring those precautions are in place so I'm hesitant to change policy, though it would be nice to lighten the timeliness burden of the reviews. Is anyone considering policy adjustments in light of the standard change?
Also, I looked for but couldn't find any guidance about this change in particular, so if there is something I've missed that clarifies expectations please let me know!
Erin

Tags: 

Top